TGFB1 and B-cell chronic lymphocytic leukemia: CLL cells drive these T-cell abnormal phenotypes by releasing factors such as IL-10 and TGF-β1, which impair T-cell activation and effector functions, ultimately facilitating CLL cell survival and proliferation [88].